The Scientific Research Team at DEM Biopharma, Inc. is dedicated to advancing immuno-oncology by conducting cutting-edge research focused on innate immune system checkpoints. Comprising a diverse group of scientists at various levels, the team collaborates to identify novel therapeutic targets, develop biologics, and utilize computational biology techniques to enhance drug discovery, ultimately driving innovations in cancer treatment.
View all